FDCDDQ
TNGX icon

Federation des caisses Desjardins du Quebec’s Tango Therapeutics TNGX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13K Sell
417
-400
-49% -$9.89K ﹤0.01% 2328
2026
Q1 		$17.1K Buy
+817
New +$11.4K ﹤0.01% 2143

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's TNGX Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec reduced its Tango Therapeutics (TNGX) stake by 49% in Q2 2026, selling an estimated $9.89K and leaving 417 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #2328.

Federation des caisses Desjardins du Quebec first reported a position in TNGX in Q1 2026 and has held it in 2 quarters since. The position peaked at $17.1K in Q1 2026. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 417 shares of Tango Therapeutics worth $13K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec sold 400 Tango Therapeutics shares in Q2 2026, an estimated $9.89K.
  • Tango Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2328 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Tango Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Federation des caisses Desjardins du Quebec's Tango Therapeutics position peaked at $17.1K in Q1 2026.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.